首页 / 院系成果 / 成果详情页

Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy  期刊论文  

  • 编号:
    57580947-4cfa-4741-999a-34b33d5061b1
  • 作者:
    Yao, Chong#[1,2]Liu, Jiyong#[1]Wu, Xin#[3]Tai, Zongguang[1];Gao, Yuan[1];Zhu, Quangang(朱全刚)[4]Li, Jiafei[5];Zhang, Lijuan[1];Hu, Chuling[1];Gu, Fenfen[1];Gao, Jing*[6]Gao, Shen*[1]
  • 语种:
    英文
  • 期刊:
    JOURNAL OF CONTROLLED RELEASE ISSN:0168-3659 2016 年 232 卷 (203 - 214) ; JUN 28
  • 收录:
  • 关键词:
  • 摘要:

    The co-delivery of chemotherapeutic drugs and microRNAs (miR) represents a promising strategy for tumor therapy due to the synergistic effect achieved. In the present study, hydrophobic doxorubicin (DOX) and negatively charged miR-34a were simultaneously delivered via a reducible self-assembling disulfide cross-linked stearyl-peptide-based micellar system (SHRss) using poly(L-arginine)-poly(L-histidine)-stearoyl as the copolymer building unit. The nanoscale SHRss micelles exhibited a low critical micelle concentration (CMC) with positive surface charge. In addition, the present micellar system facilitated the escape of miR-34a from the endosome and release of DOX into the cell nucleus, leading to the downregulation of silent information regulator 1 (SIRT1) expression and inhibition of DU145 and PC3 androgen-independent prostate cancer cell proliferation. In addition, DOX and miR-34a, delivered by SHRss micelles, passively targeted tumor tissue. Furthermore, a synergistic anti-proliferative effect was observed compared with DOX or miR-34a treatment alone in vivo. Our results demonstrate that the SHRss micelles developed in the present study represent a promising approach for combined delivery of gene agents and hydrophobic chemotherapeutic drugs in cancer therapy. (C) 2016 Elsevier B.V. All rights reserved.

  • 推荐引用方式
    GB/T 7714:
    Yao Chong,Liu Jiyong,Wu Xin, et al. Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy [J].JOURNAL OF CONTROLLED RELEASE,2016,232:203-214.
  • APA:
    Yao Chong,Liu Jiyong,Wu Xin,Tai Zongguang,&Gao Shen.(2016).Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy .JOURNAL OF CONTROLLED RELEASE,232:203-214.
  • MLA:
    Yao Chong, et al. "Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy" .JOURNAL OF CONTROLLED RELEASE 232(2016):203-214.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:14 下载次数:0
浏览次数:14
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部